[1] Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence andmortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021,71(3):209-249. [2] Cao W, Chen H, Yu Y, et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020[J]. Chin Med J (Engl), 2021,134(7):783-791. [3] 李建, 张尧, 胡登敏, 等. 1990—2019年中国人群早发性结直肠癌疾病负担及变化趋势分析[J]. 现代预防医学, 2022,49(19):3468-3473. [4] Yang Y,Han Z,Li X,et al. Epidemiology and risk factors of colorectal cancer in China[J]. Chin J Cancer Res, 2020,32(6):729-741. [5] Pallesen AVJ,Herrstedt J,Westendorp RGJ,et al. Differential effects of colorectal cancer screening across sociodemographic groups in Denmark: a register-based study[J]. Acta Oncol, 2021,60(3):323-332. [6] 国家卫生健康委员会. 中国结直肠癌诊疗规范(2020年版)[J]. 中华外科杂志, 2020,58(8):561-585. [7] Wang T, Tsang T, Turshudzhyan A, et al. Updates, controversies, and emerging approaches in colorectal screening[J]. Curēus, 2021,13(9):e17844. [8] 国家癌症中心中国结直肠癌筛查与早诊早治指南制定专家组. 中国结直肠癌筛查与早诊早治指南(2020, 北京)[J]. 中华肿瘤杂志, 2021,43(1):16-38. [9] Shaukat A,Kaalby L,Baatrup G,et al. Effects of screening compliance on long-term reductions in all-cause and colorectal cancer mortality[J]. Clin Gastroenterol Hepatol, 2021,19(5):967-975. [10] 李建英,谭黎明,陈立华,等. 结直肠组织肿瘤标志物检测在结直肠癌早期诊断中的应用[J]. 实用预防医学, 2022,29(12):1448-1451. [11] 王乐, 李辉章, 朱陈, 等. 浙江省2013—2018年城市居民结直肠癌筛查结果及成本效果分析[J]. 中华流行病学杂志, 2020,41(12):2080-2086. [12] 郭兰伟, 张韶凯, 刘曙正, 等. 2013—2019年河南省城市癌症早诊早治项目地区人群结肠镜筛查结果和依从性分析[J]. 中华预防医学杂志, 2021,55(3):353-358. [13] Bretthauer M, Loberg M, Wieszczy P, et al. Effect of colonoscopy screening on risks of colorectal cancer and relateddeath[J]. N Engl J Med, 2022,387(17):1547-1556. [14] 穆合塔尔穆再排尔, 金花, 于德华. 大肠癌初筛阳性人群健康素养对肠镜检查依从性的影响研究[J]. 中国全科医学, 2022,25(31):3944-3948. [15] 周琴, 李海麟, 谷玉婷, 等. 广州市社区人群大肠癌筛查项目成本效益分析[J]. 实用预防医学, 2020,27(6):674-677. [16] Bretthauer M, Loberg M, Wieszczy P, et al. Effect of colonoscopy screening on risks of colorectal cancer and relateddeath[J]. N Engl J Med, 2022,387(17):1547-1556. [17] Akimoto N, Ugai T, Zhong R, et al. Rising incidence of early-onset colorectal cancer - a call to action[J]. Nat Rev Clin Oncol, 2021,18(4):230-243. [18] Vabi BW,Gibbs JF,Parker GS. Implications of the growing incidence of global colorectal cancer[J]. J Gastrointest Oncol, 2021,12(S2):S387-S398. [19] 陈宏达, 李霓, 任建松, 等. 中国城市结直肠癌高危人群的结肠镜筛查依从性及其相关因素分析[J]. 中华预防医学杂志, 2018,52(3):231-237. [20] 郑莹, 王泽洲. 全球结直肠癌流行数据解读[J]. 中华流行病学杂志, 2021,42(1):149-152. [21] Dairi O,Anderson JC,Butterly LF. Why is colorectal cancer increasing in younger age groups in the United States?[J]. Expert Rev Gastroenterol Hepatol, 2021,15(6):623-632. [22] Shah SK, Narcisse MR, Hallgren E, et al. Assessment of colorectal cancer screening disparities in U.S. men and women using a demographically representative sample[J]. Cancer Res Commun, 2022,2(6):561-569. [23] Li W, Zhao T, Wu D, et al. Colorectal cancer in ulcerative colitis: mechanisms, surveillance and chemoprevention[J]. Curr Cncol, 2022,29(9):6091-6114. [24] Mangas-Sanjuan C, Jover R. Familial colorectal cancer[J]. Best Pract Res Clin Gastroenterol, 2022,58-59. [25] Giuliani C. The flavonoid quercetin induces AP-1 activation in FRTL-5 thyroid cells[J]. Antioxidants (Basel), 2019,8(5):112. [26] 刘成成, 石春雷, 石菊芳, 等. 2015—2017年中国城市居民肿瘤预防意识健康素养及相关因素分析[J]. 中华预防医学杂志, 2020,54(1):47-53. [27] Sung J, Luk A, Ng S, et al. Effectiveness of one-stop screening for colorectal, breast, and prostate cancers: a population-based feasibility study[J]. Front Oncol, 2021,11:631666.
2024, Vol. 31 
